High-Safety Bronchoscope for Medical Use - Zero Infection Risk

Name: High-Safety Bronchoscope for Medical Use - Zero Infection Risk
Brand: Guangdong Power on Mould Co., Ltd.
SKU: 2255113745

Guangdong, ChinaGuangdong Power on Mould Co., Ltd.

US$200.00

100 Pieces

Sample price:US$200.00/piece.Request sample

Product profile

Customization

Available

Classification

Imaging Diagnostic Equipment

Certification

CE, ISO13485

Model NO.

LR-BR5501

Safety

Zero Risk of Cross-Infection

Basic Functions

Ease of Operation

Use

No Pre-Treatment Required; Ready to Use Upon Openi

Bending Angle

up/Down: 210°

Trademark

POM

Origin

Dongguan, China

HS Code

9018903010

Production Capacity

50000 Units

Company profile

R&D CapabilitiesManagement CertificationODM ServicesOEM Services

Guangdong Power on Mould Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 13 YearsNearest Port: Shenzhen PortAverage Response Time: ≤2.88h

AI-Powered supplier vetting

SummaryGuangdong Power on Mould Co., Ltd. is a China-based manufacturer/factory in Dongguan, Guangdong, producing plastic products for the health and medicine sector. It reports ISO 9001:2015 certification, 20 R&D engineers, customization from samples and designs, OEM service for popular brands, and documented procedures for complaints, corrective actions, finished-product inspection, and supplier-service assessment. It has inventory capability, accepts several trade and payment terms, and reports one-month lead times in both peak and off-seasons. However, the available evidence shows no SDK, overseas warehouse, overseas showroom, overseas agents or branches, or valid manufacturing-capacity contract with related subcontractors. No Fortune 500 cooperation is reported, and financial information is insufficient for a credibility assessment. The audit record identifies TÜV Rheinland, with a stated audit evaluation result of 0; the meaning of that result is not provided.

Supplier typeThe supplier is identified as Guangdong Power on Mould Co., Ltd., a manufacturer/factory located in Dongguan, Guangdong, China. Its primary offered product is plastic products, with commercial engagement in health and medicine.

CertificationsThe supplier reports an ISO 9001:2015 management-system certificate. A TÜV Rheinland audit record is also listed with validity from September 17, 2025 to September 16, 2026, although the stated audit evaluation result of 0 is not explained.

After-Sales capabilityDocumented and followed procedures exist for customer complaints and corrective/preventive actions, supporting structured service handling. Inventory service is available, but overseas warehouse, showroom, agents/branches, and overseas-service coverage are reported as unavailable or zero.

R&D capabilityThe supplier reports 20 R&D engineers, indicating an established R&D staffing base, but it has no available SDK. The evidence supports personnel capacity but does not establish broader innovation performance.

Production capacityThe supplier is a factory with quality assurance, documented finished-product inspection, inventory capability, and one-month average lead times in both peak and off-seasons. However, no valid manufacturing-capacity contract exists with related subcontractors, which is a stated production-governance deficiency.

Customization capabilityThe supplier supports customization from samples, designs, full and flexible customization, minor customization, and OEM services for popular brands. It also identifies quality-control capability for its own-brand products as POWER ON MOULD, supporting customized manufacturing capability.

Client casesEvidence includes 13 years of export experience, 51%–70% export sales, OEM service for popular brands, participation in the WHX offline trade show, and repeat-buyer preference of 80%–100%. However, no specific customer names or verifiable case details are provided, and Fortune 500 cooperation is explicitly reported as absent.